Envelope protein component of the entry-fusion complex. It facilitates viral membrane fusion with the host cell membrane during viral entry and plays a role in cell-cell fusion (syncytium formation).
KEGG: vg:1486684
FPV136 is located within the 288-kbp FPV genome, which consists of a central coding region bounded by identical 9.5-kbp inverted terminal repeats . Like other poxvirus proteins, FPV136 is encoded within the genome region containing genes involved in virion structure and protein processing. Researchers should note that the FPV genome organization, while exhibiting colinearity with other chordopoxviruses, is interrupted by translocation and a major inversion that may affect protein function and expression .
Methodological approach: To accurately identify and characterize the FPV136 gene, researchers should perform comparative genomic analysis using bioinformatics tools such as BLAST alignment against other poxvirus genomes. Sequence analysis software like Phred and Phrap can be used for assembly, while Consed sequence editor allows for manual editing of consensus sequences . For identifying promoter regions, researchers should generate a scoring matrix using PROFILEMAKE based on known vaccinia virus early-promoter consensus sequences.
Expression of FPV136 requires selection of an appropriate vector system based on research objectives. For vaccine development purposes, recombinant fowlpox virus vectors have proven effective for co-expression of target proteins and immunostimulatory molecules.
Methodological approach: Researchers should consider a construction strategy similar to that used for other FPV recombinants. For example, when generating novel FPV recombinants:
Culture chicken embryo fibroblast (CEF) cells and infect them with parent FPV strain
Transfect infected cells with a transfer vector containing the FPV136 gene
Allow for homologous recombination to occur during incubation
Apply selective pressure (e.g., MXH solution containing mycophenolic acid, xanthine, and hypoxanthine)
Harvest virus by freeze/thawing cycles and plaque purification under selection
The verification of recombinant virus can be performed using PCR amplification with specific primers, similar to the approach used for IL-18 insertion verification in fpIBD1 recombinants .
Purification of FPV136 requires a multi-step approach to ensure protein integrity and purity for downstream applications.
Methodological approach: Researchers should implement a purification strategy that includes:
Initial clarification of infected cell lysates through centrifugation
Affinity chromatography using epitope tags (His, FLAG, or GST) strategically added to FPV136
Size-exclusion chromatography to separate monomeric from aggregated protein
Ion-exchange chromatography for removing contaminants with different charge properties
Protein concentration determination using Bradford or BCA assays
Purity assessment by SDS-PAGE with Coomassie or silver staining
For vaccine development applications, researchers should ensure that purification methods maintain the native conformation of epitopes to preserve immunogenicity.
Verification of proper expression is critical before proceeding with functional or structural studies.
Methodological approach: Expression verification should follow a multi-technique approach:
Western blot analysis using antibodies specific to FPV136 or to added epitope tags
Immunofluorescence microscopy to confirm cellular localization
Mass spectrometry for protein identification and post-translational modification analysis
RT-PCR to confirm transcription using primers designed from the FPV136 sequence
Functional assays to verify biological activity
Similar verification approaches have been used for fpIBD1::IL-18 recombinants where PCR amplifications were set up using specific primers to confirm successful insertion .
Understanding protein-protein interactions is essential for elucidating the function of FPV136 in viral pathogenesis and host immune evasion.
Methodological approach: Researchers should employ complementary techniques for comprehensive interaction mapping:
Yeast two-hybrid screening against avian cDNA libraries
Co-immunoprecipitation followed by mass spectrometry (IP-MS)
Proximity-based labeling (BioID or APEX) to identify proteins in close proximity to FPV136 in infected cells
Surface plasmon resonance (SPR) or biolayer interferometry (BLI) for kinetic analysis of direct interactions
Fluorescence resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) for visualization of interactions in living cells
When interpreting interaction data, researchers should consider the context of FPV infection, as the presence of other viral proteins may influence interaction networks. The extensive genome colinearity interrupted by translocation and inversion in FPV suggests potentially unique protein-protein interaction landscapes compared to other poxviruses .
The effectiveness of recombinant fowlpox virus vaccines depends on proper antigen presentation and immune stimulation.
Methodological approach: To evaluate FPV136 contribution to vaccine efficacy, researchers should:
Design recombinant FPV constructs with and without FPV136
Consider co-expression with immune-enhancing cytokines (e.g., chicken interferon-γ or interleukin-18)
Evaluate antibody responses using ELISA at regular intervals post-vaccination
Assess T-cell responses by measuring CD4+ and CD8+ T-lymphocyte numbers in peripheral blood
Conduct challenge studies to determine protection levels against relevant pathogens
Compare morbidity, virus shedding, and histopathological changes between vaccinated and control groups
This approach mirrors the methodology used to evaluate rFPV-IFNγS1 efficacy against heterotypic IBV strains, which showed significant differences in T-lymphocyte numbers between vaccinated and control groups .
Understanding the three-dimensional structure of FPV136 is crucial for functional characterization and rational design of vaccines or antivirals.
Methodological approach: Researchers should pursue complementary structural biology techniques:
X-ray crystallography:
Express and purify milligram quantities of FPV136
Screen crystallization conditions systematically
Collect diffraction data at synchrotron radiation facilities
Solve structure using molecular replacement or experimental phasing methods
Cryo-electron microscopy:
Prepare purified FPV136 on grids for single-particle analysis
Collect data using high-end electron microscopes with direct electron detectors
Process images and reconstruct 3D structure
NMR spectroscopy for dynamics studies:
Isotopically label FPV136 with 15N and 13C
Collect multi-dimensional spectra
Assign resonances and calculate solution structure
Computational approaches:
Homology modeling based on related J5 homologs
Molecular dynamics simulations to predict conformational changes
Protein-protein docking with predicted interaction partners
Understanding FPV136's contribution to viral pathogenesis requires comprehensive functional studies in relevant model systems.
Methodological approach:
Generate FPV136 knockout mutants using recombination techniques
Perform comparative infection studies using wild-type and mutant viruses
Assess viral replication kinetics through growth curves in avian cell cultures
Evaluate transcriptome changes in infected cells using RNA-seq
Conduct in vivo studies in chickens to determine virulence attenuation
Perform histopathological analysis of infected tissues
Measure viral load in different organs using quantitative PCR
When analyzing pathogenesis data, researchers should consider the larger context of FPV's gene complement, which includes numerous homologs of genes encoding proteins involved in steroid biogenesis, antioxidant functions, vesicle trafficking, and other cellular processes that may affect host cell function .
Some viral proteins contain regions that are challenging to express due to hydrophobicity, toxicity, or complex folding requirements.
Methodological approach: Researchers should consider specialized expression strategies:
For hydrophobic domains:
Use fusion partners (MBP, GST, NusA) to enhance solubility
Express as split constructs covering non-hydrophobic regions
Employ membrane-mimetic systems (detergents, nanodiscs, liposomes)
For proteins affecting host cell viability:
Utilize inducible expression systems with tight regulation
Express in cell-free translation systems
Use specialized host strains with enhanced tolerance
For disulfide-rich domains:
Direct expression to oxidizing compartments (periplasm in bacteria)
Use eukaryotic expression systems with proper folding machinery
Co-express with appropriate chaperones and disulfide isomerases
Table 1. Comparison of expression systems for recombinant FPV136 production.
| Expression System | Advantages | Limitations | Yield Potential | Post-translational Modifications |
|---|---|---|---|---|
| E. coli | Rapid growth, simple genetics, cost-effective | Limited PTMs, inclusion body formation | High | Minimal |
| Baculovirus/Insect Cells | Eukaryotic PTMs, high expression | Higher cost, longer production time | Medium-High | Good |
| Mammalian Cells | Authentic folding, full PTMs | Highest cost, complex media | Low-Medium | Excellent |
| Avian Cell Lines | Native environment for FPV proteins | Limited genetic tools, slower growth | Medium | Native to viral host |
| Cell-Free Systems | Rapid, amenable to toxic proteins | Expensive, limited scale | Low | Minimal |
Comparative analysis of FPV136 variants can provide insights into host adaptation and virulence determinants.
Methodological approach:
Sequence multiple FPV strains to identify natural variants of FPV136
Generate a phylogenetic tree to establish evolutionary relationships
Select representative variants spanning the evolutionary diversity
Clone and express each variant using identical expression systems
Conduct standardized functional assays to compare activity
Perform complementation studies in FPV136-knockout backgrounds
Correlate functional differences with sequence variations and virulence phenotypes
Rigorous controls are critical for accurate interpretation of functional studies.
Methodological approach: Researchers should implement the following controls:
Positive controls:
Well-characterized J5 homologs from related viruses
Purified native FPV136 (if available)
Cellular proteins with similar function
Negative controls:
Catalytically inactive mutants (site-directed mutagenesis)
Structurally similar but functionally distinct proteins
Empty vector controls for expression studies
Specificity controls:
Dose-response relationships
Competition assays with unlabeled ligands
Antibody blocking experiments
Technical controls:
Multiple biological and technical replicates
Randomization and blinding where applicable
Cross-validation using orthogonal techniques
Similar control approaches were used in evaluating fpIBD1 efficacy, where unvaccinated challenged groups served as controls for vaccinated challenged groups .
Developing effective recombinant vaccines requires optimization of antigen delivery to maximize immune responses.
Methodological approach:
Evaluate different FPV promoters to control expression timing and level
Test various subcellular targeting signals (secretion, surface display)
Co-express with immunomodulatory molecules:
Chicken cytokines (IFN-γ, IL-18) to enhance cellular immunity
Molecular adjuvants to shape immune response quality
Compare administration routes (wing-web puncture, intranasal, intramuscular)
Develop prime-boost strategies using heterologous vectors
Optimize dose and boosting interval
Research has shown that recombinant fowlpox viruses co-expressing viral antigens with chicken cytokines can induce strong immune responses, as demonstrated with rFPV-IFNγS1, which protected chickens against challenge with homotypic and some heterotypic IBV strains .
Scientific research occasionally produces contradictory results that must be systematically resolved.
Methodological approach:
Replicate original experiments with identical conditions
Systematically vary experimental parameters to identify conditional factors
Employ orthogonal techniques to validate findings
Consider strain-specific or cell type-specific effects
Evaluate time-dependent phenomena through detailed kinetic studies
Collaborate with original authors to compare protocols and materials
Perform meta-analysis of multiple studies
When investigating contradictions, researchers should consider the complex nature of poxvirus genomes and the potential for contextual effects from other viral genes, as FPV contains diverse gene complements with likely host range functions .
Modern protein characterization generates complex multi-dimensional datasets requiring sophisticated analysis approaches.
Methodological approach:
For high-throughput interaction data:
Apply appropriate statistical models for interaction scoring
Use clustering algorithms to identify functional complexes
Perform network analysis to identify central nodes and modules
Integrate with public protein interaction databases
For conformational dynamics data:
Apply principal component analysis to identify major motion modes
Use time-series analysis for transitions between states
Correlate dynamic changes with functional outcomes
For immunological data:
Perform multivariate analysis to correlate immune parameters with protection
Use machine learning algorithms to identify predictive biomarkers
Apply systems biology approaches to model immune response networks
Table 2. Statistical approaches for different experimental data types in FPV136 research.
| Data Type | Recommended Statistical Approaches | Visualization Methods | Software Tools |
|---|---|---|---|
| Protein Expression Levels | ANOVA, t-tests, non-parametric tests | Bar charts, box plots | GraphPad Prism, R |
| Binding Kinetics | Non-linear regression, Scatchard analysis | Binding curves, Scatchard plots | BIAevaluation, KaleidaGraph |
| Structural Data | RMSD, RMSF, clustering algorithms | 3D structures, distance maps | PyMOL, UCSF Chimera |
| Immunological Responses | Mixed-effects models, survival analysis | Kaplan-Meier plots, heatmaps | R (survival package), FlowJo |
| RNA-seq/Transcriptomics | DESeq2, edgeR, GSEA | Volcano plots, enrichment maps | R/Bioconductor, GSEA software |
Computational approaches can guide experimental design when direct data is limited.
Methodological approach:
Homology-based function prediction:
Identify homologs in other poxviruses and cellular organisms
Perform phylogenetic analysis to identify conserved domains
Use HHpred or similar sensitive sequence comparison tools
Structural prediction and analysis:
Generate 3D models using AlphaFold2 or RoseTTAFold
Identify potential binding pockets and active sites
Perform in silico ligand docking to predict binding partners
Genomic context analysis:
Examine genomic neighborhood for functionally related genes
Identify co-expression patterns across infection time course
Look for conserved operonic structures across poxvirus species
Researchers should note that comparative genomic analysis of FPV with other chordopoxviruses has revealed extensive genome colinearity which is interrupted in FPV by a translocation and a major inversion , which may provide context for FPV136 function.
Understanding FPV136 structure and function can enhance vaccine design strategies.
Methodological approach:
Incorporate FPV136 modifications that:
Enhance stability in vaccine formulations
Improve immunogenicity of co-expressed antigens
Optimize viral replication in production systems
Develop rational attenuation strategies:
Engineer conditional mutations in FPV136
Design compensatory modifications that maintain manufacturing yield
Create temperature-sensitive variants for controlled replication
Enhance vector performance:
Modify FPV136 to extend transgene expression duration
Engineer tissue-specific activity for targeted immunization
Optimize for reduced pre-existing immunity interference
The rational design of safer and more effective FPV vaccines requires complete information on viral genes associated with virulence and host range, and understanding how these genes function in viral pathogenesis, immune evasion, and avian host range .
Specific detection of FPV136 can have diagnostic applications in veterinary medicine and research.
Methodological approach:
Develop antibody-based detection methods:
Generate monoclonal antibodies against conserved FPV136 epitopes
Design ELISA protocols for detecting FPV136 in clinical samples
Develop immunohistochemistry procedures for tissue section analysis
Nucleic acid detection approaches:
Design PCR primers specific to conserved regions of FPV136
Develop quantitative PCR assays with appropriate controls
Create multiplex assays to simultaneously detect multiple viral targets
Rapid field detection systems:
Engineer lateral flow assays using FPV136-specific antibodies
Develop isothermal amplification methods for point-of-care testing
Create biosensor platforms for resource-limited settings
Similar PCR-based approaches have been used to detect IBDV in experimental studies, where RNA extraction from samples followed by real-time quantitative RT-PCR allowed sensitive viral detection .